Post-market Re-evaluation on Safety of Yuxingcao (Houttuyniae Herba) Preparations
10.3870/j.issn.1004-0781.2016.08.001
- VernacularTitle:鱼腥草制剂上市后安全性再评价?
- Author:
Jianhong WU
;
Xiaoyan YANG
;
Qiangni LIU
;
Ping YIN
;
Fandian ZENG
- Publication Type:Journal Article
- Keywords:
Yuxingcao (Houttuyniae Herba) preparations;
Re-evaluation;
Medication risk;
Adverse drug reaction
- From:
Herald of Medicine
2016;35(8):803-808
- CountryChina
- Language:Chinese
-
Abstract:
Objective To retrospectively analyze adverse drug reaction ( ADR ) of Yuxingcao ( Houttuyniae Herba ) preparations, thus provide reference for post-market re-evaluation of traditional Chinese medicine injections. Methods The ADR from Chinese ADR spontaneous reporting system database from 2006 to 2008 were analyzed by descriptive statistic method. Results A total of 2 282 reports on ADR induced by Yuxingcao preparations were concluded in this study, and 98.07% ADR of the total cases ( 2 238 case ) were due to vein injection. The main ADR were anaphylactic reactions which injure multiple systems and organs.The most frequent symptoms were respiratory system damage, such as expiratory dyspnea (with the incidence rate of 27.25%).Skin and mucous membrane were the secondly susceptible (with the incidence rate of 21.35%).The ratio of serious ADR in the total case was 13.50% (308 case), rate of allergic shock was 8.37% (191 case), and 22 cases were dead. Conclusion By strengthening the ADR reporting and monitoring, the risk of traditional Chinese medicine injection could be controlled.Safety re-evaluation should be performed to overall enhance safety, effectiveness and quality control of these kinds of medicine.
